Sign up to save your podcasts
Or
Share ACCEL Lite: Selecting an Oral P2Y12 Inhibitor Post-MI: What’s the Best Choice?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACCEL Lite: Selecting an Oral P2Y12 Inhibitor Post-MI: What’s the Best Choice?
In this interview, Francesco Franchi, MD and Spencer B. King III, MD, MACC, with Matt A. Cavender MD, MPH, FACC, discuss how to make the best choice when selecting an oral P2Y12 inhibitor post-MI.
View all episodes
By American College of Cardiology
3.8
5454 ratings
In this interview, Francesco Franchi, MD and Spencer B. King III, MD, MACC, with Matt A. Cavender MD, MPH, FACC, discuss how to make the best choice when selecting an oral P2Y12 inhibitor post-MI.
More shows like ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
View all
JAMA Editors' Summary
136 Listeners
NEJM This Week
317 Listeners
JAMA Clinical Reviews
496 Listeners
JACC This Week
169 Listeners
This Week in Cardiology
883 Listeners
Mayo Clinic Talks
296 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
137 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
92 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Cardionerds: A Cardiology Podcast
429 Listeners
The Curious Clinicians
372 Listeners
Mayo Clinic Cardiovascular CME
35 Listeners